宏源药业：公司六氟磷酸锂和六氟磷酸钠产品生产和销售正常，满产满销

Core Viewpoint - Hongyuan Pharmaceutical reported that the production and sales of lithium hexafluorophosphate and sodium hexafluorophosphate are currently operating normally, with full production and sales capacity [2] Group 1 - The company confirmed that its lithium hexafluorophosphate product is in full production and sales [2] - The company also stated that its sodium hexafluorophosphate product is experiencing the same operational status [2]